Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue
Molecules · 2023
DOI: 10.3390/molecules28114446 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Yukiko Yasuoka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara 252-0374, Japan. Hauptthemen laut MEDLINE: Erythropoietin, Body Fluids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science Research Promotion Fund from Kitasato University Medical Center, a Grant-in-Aid for Scientific Research from the Ministry of Education, Vulture, Sports, Science and Technology of Japan, Science Research Promotion Fund from Kitasato University Medical Center.
Abstract (Originalsprache)
Detection of erythropoietin (Epo) was difficult until a method was developed by the World Anti-Doping Agency (WADA). WADA recommended the Western blot technique using isoelectric focusing (IEF)-PAGE to show that natural Epo and injected erythropoiesis-stimulating agents (ESAs) appear in different pH areas. Next, they used sodium N-lauroylsarcosinate (SAR)-PAGE for better differentiation of pegylated proteins, such as epoetin β pegol. Although WADA has recommended the use of pre-purification of samples, we developed a simple Western blotting method without pre-purification of samples. Instead of pre-purification, we used deglycosylation of samples before SDS-PAGE. The double detection of glycosylated and deglycosylated Epo bands increases the reliability of the detection of Epo protein. All of the endogenous Epo and exogenous ESAs shift to 22 kDa, except for Peg-bound epoetin β pegol. All endogenous Epo and exogenous ESAs were detected as 22 kDa deglycosylated Epo by liquid chromatography/mass spectrum (LC/MS) analysis. The most important factor for the detection of Epo is the selection of the antibody against Epo. WADA recommended clone AE7A5, and we used sc-9620. Both antibodies are useful for the detection of Epo protein by Western blotting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara 252-0374, Japan.
- Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.
- Renal Division, Department of Medicine, Emory University School of Medicine, 1639 Pierce Drive, WMB Room 3313, Atlanta, GA 30322, USA.
- Division of Internal Medicine, Kitasato University Medical Center, 6-100 Arai, Kitamoto 364-8501, Japan.
ORCID-Profile: Yukiko Yasuoka, Yuichiro Izumi, Hiroshi Nonoguchi
Förderung
- The Science Research Promotion Fund from Kitasato University Medical Center
- a Grant-in-Aid for Scientific Research from the Ministry of Education, Vulture, Sports, Science and Technology of Japan
- Science Research Promotion Fund from Kitasato University Medical Center
- Ministry of Education, Culture, Sports, Sciences and Technology of Japan
Zitieren
APA
Yasuoka, Y., Izumi, Y., Sands, J. M., Kawahara, K., & Nonoguchi, H. (2023). Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue. Molecules. https://doi.org/10.3390/molecules28114446
Vancouver
Yasuoka Y, Izumi Y, Sands JM, Kawahara K, Nonoguchi H. Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue. Molecules. 2023. doi:10.3390/molecules28114446
BibTeX
@article{Yasuoka2023,
author = {Yasuoka, Yukiko and Izumi, Yuichiro and Sands, Jeff M and Kawahara, Katsumasa and Nonoguchi, Hiroshi},
title = {Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28114446}
}
EUVIMED